ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Empowering voices: inspiring women in medicinal chemistry [Editorial] (2024)
Blanco, Maria Jesus ; Bronson, Joanne J ; DiMauro, Erin F ; Dzierba, Carolyn ; Eggen, MariJean ; Garner, Amanda L ; Georg, Gunda ; Giarolla, Jeanine ; Goodwin, Nicole C ; Davies, Melissa C. Grenier ; Luevano, Carrie Haskell ; Holzgrabe, Ulrike ; Huang, Rong ; Lagiakos, H. Rachel ; Leftheris, Katerina ; Martin, Yvonne; Matos, Maria João ; Dracka, Tricia L. May
Fonte: Journal of Medicinal Chemistry. Unidade: FCF
Assuntos: MULHERES, QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLANCO, Maria Jesus et al. Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.1021/acsmedchemlett.4c00097. Acesso em: 21 ago. 2024. , 2024
APA
Blanco, M. J., Bronson, J. J., DiMauro, E. F., Dzierba, C., Eggen, M. J., Garner, A. L., et al. (2024). Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1021/acsmedchemlett.4c00097
NLM
Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
Vancouver
Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
Artigo de periodico
Potential use of bixin beyond function as a natural colourant in food and cosmetics (2024)
Takamoto, Rafael Teruiti de Oliveira; Hübner, Alexandra Almeida; Matuo, Míriam Cristina Sakuragui; Kikuchi, Irene Satiko
Fonte: Natural Product Research. Unidade: FCF
Assuntos: CAROTENOIDES, URUCUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKAMOTO, Rafael Teruiti de Oliveira et al. Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/14786419.2024.2350634. Acesso em: 21 ago. 2024.
APA
Takamoto, R. T. de O., Hübner, A. A., Matuo, M. C. S., & Kikuchi, I. S. (2024). Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research. doi:10.1080/14786419.2024.2350634
NLM
Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
Vancouver
Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
Trabalho de evento-resumo
Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus (2024)
Contelli, Ana P; Ferraz, Gustavo C; Ferraz, Wítor R; Penteado, André Berndt ; Trossini, Gustavo Henrique Goulart ; Pedrozo, Eliane Correa
Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: FCF, EEL
Assuntos: ENZIMAS, VENENOS DE ORIGEM ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTELLI, Ana P et al. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos. Acesso em: 21 ago. 2024.
APA
Contelli, A. P., Ferraz, G. C., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., & Pedrozo, E. C. (2024). Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
NLM
Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 ago. 21 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
Vancouver
Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 ago. 21 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
Artigo de periodico
Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment (2024)
Passarin, Paula Beatriz Silva ; Lourenço, Felipe Rebello
Fonte: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Assuntos: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 21 ago. 2024.
APA
Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907
NLM
Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
Vancouver
Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
Artigo de periodico
The scenario of clays and clay minerals use in cosmetics/Dermocosmetics (2024)
Sarruf, Fernanda Daud ; Contreras, Vecxi Judith Pereda; Martinez, Renata Miliani ; Velasco, Maria Valéria Robles ; Baby, André Rolim
Fonte: Cosmetics. Unidade: FCF
Assuntos: ARGILAS, COSMÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARRUF, Fernanda Daud et al. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, v. 11, p. 1-21, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cosmetics11010007. Acesso em: 21 ago. 2024.
APA
Sarruf, F. D., Contreras, V. J. P., Martinez, R. M., Velasco, M. V. R., & Baby, A. R. (2024). The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, 11, 1-21. doi:10.3390/cosmetics11010007
NLM
Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007
Vancouver
Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007
Artigo de periodico
Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)
Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar
Fonte: Ageing Research Reviews. Unidade: FCF
Assuntos: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 21 ago. 2024.
APA
Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
NLM
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Vancouver
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Artigo de periodico
In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)
Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 21 ago. 2024.
APA
Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
NLM
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Vancouver
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Artigo de periodico
Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin (2024)
Richter, Luca Maurice ; Al-Gousous, Jozef ; Araujo, Gabriel Lima Barros de ; Davies, Neal M ; Löbenberg, Raimar
Fonte: Journal of Drug Delivery Science and Technology. Unidade: FCF
Assuntos: DEPRESSÃO, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 21 ago. 2024.
APA
Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305
NLM
Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
Vancouver
Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305
Artigo de periodico
How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? (2024)
Savino, Débora Feliciano; Silva, João Vitor da ; Santos, Soraya da Silva ; Lourenço, Felipe Rebello ; Giarolla, Jeanine
Fonte: Journal of Molecular Modeling. Unidade: FCF
Assuntos: ZIKA VÍRUS, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAVINO, Débora Feliciano et al. How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease?. Journal of Molecular Modeling, v. 30, n. 2, p. 1-19, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s00894-024-05843-1. Acesso em: 21 ago. 2024.
APA
Savino, D. F., Silva, J. V. da, Santos, S. da S., Lourenço, F. R., & Giarolla, J. (2024). How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? Journal of Molecular Modeling, 30( 2), 1-19. doi:10.1007/s00894-024-05843-1
NLM
Savino DF, Silva JV da, Santos S da S, Lourenço FR, Giarolla J. How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? [Internet]. Journal of Molecular Modeling. 2024 ; 30( 2): 1-19.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1007/s00894-024-05843-1
Vancouver
Savino DF, Silva JV da, Santos S da S, Lourenço FR, Giarolla J. How do physicochemical properties contribute to inhibitory activity of promising peptides against Zika Virus NS3 protease? [Internet]. Journal of Molecular Modeling. 2024 ; 30( 2): 1-19.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1007/s00894-024-05843-1
Monografia/livro
Immunotherapy against lung cancer: emerging opportunities and challenges (2024)
Bhatt, Shvetank ; Eri, Rajaraman; Goh, Bey Hing ; Paudel, Keshav Raj ; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal
Unidade: FCF
Assuntos: IMUNOTERAPIA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BHATT, Shvetank et al. Immunotherapy against lung cancer: emerging opportunities and challenges. . Singapore: Springer. . Acesso em: 21 ago. 2024. , 2024
APA
Bhatt, S., Eri, R., Goh, B. H., Paudel, K. R., Pinto, T. de J. A., & Dua, K. (2024). Immunotherapy against lung cancer: emerging opportunities and challenges. Singapore: Springer.
NLM
Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 ago. 21 ]
Vancouver
Bhatt S, Eri R, Goh BH, Paudel KR, Pinto T de JA, Dua K. Immunotherapy against lung cancer: emerging opportunities and challenges. 2024 ;[citado 2024 ago. 21 ]
Artigo de periodico
Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial (2024)
Ramos, Mily Constanza Moreno; Velasco, Maria Valéria Robles ; Bueno, Mariana; Veríssimo, Maria De La Ó Ramallo
Fonte: Skin Pharmacology and Physiology. Unidades: FCF, EE
Assuntos: RECÉM-NASCIDO, PELE, HIGIENE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Mily Constanza Moreno et al. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial. Skin Pharmacology and Physiology, v. 36, n. 6, p. 267–277, 2024Tradução . . Disponível em: https://dx.doi.org/10.1159/000536066. Acesso em: 21 ago. 2024.
APA
Ramos, M. C. M., Velasco, M. V. R., Bueno, M., & Veríssimo, M. D. L. Ó. R. (2024). Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial. Skin Pharmacology and Physiology, 36( 6), 267–277. doi:10.1159/000536066
NLM
Ramos MCM, Velasco MVR, Bueno M, Veríssimo MDLÓR. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial [Internet]. Skin Pharmacology and Physiology. 2024 ; 36( 6): 267–277.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1159/000536066
Vancouver
Ramos MCM, Velasco MVR, Bueno M, Veríssimo MDLÓR. Effects of liquid and bar soaps on the skin of Brazilian Sewborns: a randomized controlled trial [Internet]. Skin Pharmacology and Physiology. 2024 ; 36( 6): 267–277.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1159/000536066
Artigo de periodico
Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states (2024)
Nascimento, Lucas Adriano do ; Ferreira, Glaucio Monteiro ; Ferreira, Elizabeth Igne
Fonte: Journal of Biomolecular Structure and Dynamics. Unidade: FCF
Assuntos: MACRÓFAGOS, SISTEMA IMUNE, LISOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Lucas Adriano do e FERREIRA, Glaucio Monteiro e FERREIRA, Elizabeth Igne. Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states. Journal of Biomolecular Structure and Dynamics, v. 42, n. 12, p. 6448–6454, 2024Tradução . . Disponível em: https://doi.org/10.1080/07391102.2023.2235603. Acesso em: 21 ago. 2024.
APA
Nascimento, L. A. do, Ferreira, G. M., & Ferreira, E. I. (2024). Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states. Journal of Biomolecular Structure and Dynamics, 42( 12), 6448–6454. doi:10.1080/07391102.2023.2235603
NLM
Nascimento LA do, Ferreira GM, Ferreira EI. Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states [Internet]. Journal of Biomolecular Structure and Dynamics. 2024 ; 42( 12): 6448–6454.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1080/07391102.2023.2235603
Vancouver
Nascimento LA do, Ferreira GM, Ferreira EI. Exploring the conformational dynamics ofthe CRD4: a model for receptor lysosomalactivity shifts in search of 'sweet’ and ‘sour’states [Internet]. Journal of Biomolecular Structure and Dynamics. 2024 ; 42( 12): 6448–6454.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1080/07391102.2023.2235603
Artigo de periodico
SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
Hassanie, Haifa ; Penteado, André Berndt ; Almeida, Larissa Costa de ; Calil, Raisa Ludmila; Emery, Flavio da Silva ; Costa-Lotufo, Letícia Veras ; Trossini, Gustavo Henrique Goulart
Fonte: RSC Medicinal Chemistry. Unidades: FCFRP, ICB, FCF
Assuntos: NEOPLASIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 21 ago. 2024.
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1039/D3MD00366C
Artigo de periodico
Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products (2024)
Lourenço, Felipe Rebello ; Silva, Ricardo Jorge Neves Bettencourt da
Fonte: Journal of AOAC International. Unidade: FCF
Assunto: MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOURENÇO, Felipe Rebello e SILVA, Ricardo Jorge Neves Bettencourt da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products. Journal of AOAC International, 2024Tradução . . Disponível em: https://dx.doi.org/10.1093/jaoacint/qsae044. Acesso em: 21 ago. 2024.
APA
Lourenço, F. R., & Silva, R. J. N. B. da. (2024). Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products. Journal of AOAC International. doi:10.1093/jaoacint/qsae044
NLM
Lourenço FR, Silva RJNB da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products [Internet]. Journal of AOAC International. 2024 ;[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1093/jaoacint/qsae044
Vancouver
Lourenço FR, Silva RJNB da. Simplified and detailed evaluations of the uncertainty of the measurement of microbiological contamination of Pharmaceutical Products [Internet]. Journal of AOAC International. 2024 ;[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1093/jaoacint/qsae044
Artigo de periodico
Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation (2024)
Amaral, Gustavo Kenji Toko Purcino do; Lourenço, Felipe Rebello
Fonte: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assuntos: MEDIÇÃO DE RISCO, MÉTODO DE MONTE CARLO, QUALIDADE DOS MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Gustavo Kenji Toko Purcino do e LOURENÇO, Felipe Rebello. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences, v. 60, p. 1-9, 2024Tradução . . Disponível em: https://dx.doi.org/10.1590/s2175-97902024e23565. Acesso em: 21 ago. 2024.
APA
Amaral, G. K. T. P. do, & Lourenço, F. R. (2024). Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation. Brazilian Journal of Pharmaceutical Sciences, 60, 1-9. doi:10.1590/s2175-97902024e23565
NLM
Amaral GKTP do, Lourenço FR. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2024 ; 60 1-9.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1590/s2175-97902024e23565
Vancouver
Amaral GKTP do, Lourenço FR. Risk of false conformity decisions due to measurement uncertainty of Active Pharmaceutical Ingredient: a multiparametric evaluation [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2024 ; 60 1-9.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1590/s2175-97902024e23565
Artigo de periodico
Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry (2024)
Ruscinc, Nadia ; Serafim, Ricardo Augusto Massarico; Almeida, Cíntia; Rosado, Catarina ; Baby, André Rolim
Fonte: Fronters Chemistry. Unidade: FCF
Assuntos: POLIFENÓIS, COSMÉTICOS, ANTI-INFLAMATÓRIOS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSCINC, Nadia et al. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Fronters Chemistry, v. 12, p. 1-11 art. 1400881, 2024Tradução . . Disponível em: https://dx.doi.org/10.3389/fchem.2024.1400881. Acesso em: 21 ago. 2024.
APA
Ruscinc, N., Serafim, R. A. M., Almeida, C., Rosado, C., & Baby, A. R. (2024). Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry. Fronters Chemistry, 12, 1-11 art. 1400881. doi:10.3389/fchem.2024.1400881
NLM
Ruscinc N, Serafim RAM, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry [Internet]. Fronters Chemistry. 2024 ; 12 1-11 art. 1400881.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.3389/fchem.2024.1400881.
Vancouver
Ruscinc N, Serafim RAM, Almeida C, Rosado C, Baby AR. Challenging the safety and efficacy of topically applied chlorogenic acid, apigenin, kaempferol, and naringenin by HET-CAM, HPLC-TBARS-EVSC, and laser Doppler flowmetry [Internet]. Fronters Chemistry. 2024 ; 12 1-11 art. 1400881.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.3389/fchem.2024.1400881.
Artigo de periodico
Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets (2024)
Bobadilla, Vanessa Saldaña; Villanueva, Cintia P. Barreto; Gasco, Frizzi J. Ganoza; Chauca, Enma Perez; Aquiño, Olga E. Caballero; Rodriguez, Ana E. Mantilla; Plasencia, Pedro Marcelo Alva; Aurora-Prado, Maria Segunda
Fonte: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF
Assuntos: ESPECTROFOTOMETRIA, BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOBADILLA, Vanessa Saldaña et al. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, v. 12, n. 3, p. 539-547, 2024Tradução . . Disponível em: https://dx.doi.org/10.56499/jppres23.1846_12.3.539. Acesso em: 21 ago. 2024.
APA
Bobadilla, V. S., Villanueva, C. P. B., Gasco, F. J. G., Chauca, E. P., Aquiño, O. E. C., Rodriguez, A. E. M., et al. (2024). Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets. Journal of Pharmacy and Pharmacognosy Research, 12( 3), 539-547. doi:10.56499/jppres23.1846_12.3.539
NLM
Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539
Vancouver
Bobadilla VS, Villanueva CPB, Gasco FJG, Chauca EP, Aquiño OEC, Rodriguez AEM, Plasencia PMA, Aurora-Prado MS. Development and validation of a UV spectrophotometric method for biowaiver studies in pyrazinamide tablets [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2024 ; 12( 3): 539-547.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.56499/jppres23.1846_12.3.539
Artigo de periodico
HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review (2024)
Felippini, Arturo; Biglia, Luiza Vasconcelos; Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo
Fonte: Health Policy. Unidade: FCF
Assuntos: DOENÇAS RARAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FELIPPINI, Arturo et al. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, v. 144, p. 1-8 art. 105080, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.healthpol.2024.105080. Acesso em: 21 ago. 2024.
APA
Felippini, A., Biglia, L. V., Lima, T. de M., & Aguiar, P. M. (2024). HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, 144, 1-8 art. 105080. doi:10.1016/j.healthpol.2024.105080
NLM
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080
Vancouver
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2024 ago. 21 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080
Trabalho de evento-resumo
Molecular modeling and structural comparison of leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery (2024)
Penteado, André Berndt ; Trossini, Gustavo Henrique Goulart
Fonte: Anais. Nome do evento: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidade: FCF
Assuntos: LEISHMANIA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PENTEADO, André Berndt e TROSSINI, Gustavo Henrique Goulart. Molecular modeling and structural comparison of leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos. Acesso em: 21 ago. 2024.
APA
Penteado, A. B., & Trossini, G. H. G. (2024). Molecular modeling and structural comparison of leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
NLM
Penteado AB, Trossini GHG. Molecular modeling and structural comparison of leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery [Internet]. Anais. 2024 ;[citado 2024 ago. 21 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
Vancouver
Penteado AB, Trossini GHG. Molecular modeling and structural comparison of leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery [Internet]. Anais. 2024 ;[citado 2024 ago. 21 ] Available from: https://www.eventweb.com.br/rasbq2024/home-event/schedule.php?q=&area=todas&sessao=todas&tipo=1#trabalhos
Trabalho de evento-resumo
Development of risk-management approach in additive manufacturing of orthopedic implants (2024)
Lirio, Adriana Cogo Malgueiro ; Pinto, Terezinha de Jesus Andreoli
Fonte: Proceedings. Nome do evento: World Congress on Recent Advances in Nanotechnology/RAN. Unidade: FCF
Assuntos: MANUFATURA ADITIVA, ORTOPEDIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIRIO, Adriana Cogo Malgueiro e PINTO, Terezinha de Jesus Andreoli. Development of risk-management approach in additive manufacturing of orthopedic implants. 2024, Anais.. London: International Aset Inc., 2024. Disponível em: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf. Acesso em: 21 ago. 2024.
APA
Lirio, A. C. M., & Pinto, T. de J. A. (2024). Development of risk-management approach in additive manufacturing of orthopedic implants. In Proceedings. London: International Aset Inc. Recuperado de https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf
NLM
Lirio ACM, Pinto T de JA. Development of risk-management approach in additive manufacturing of orthopedic implants [Internet]. Proceedings. 2024 ;[citado 2024 ago. 21 ] Available from: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf
Vancouver
Lirio ACM, Pinto T de JA. Development of risk-management approach in additive manufacturing of orthopedic implants [Internet]. Proceedings. 2024 ;[citado 2024 ago. 21 ] Available from: https://avestia.com/RAN2024_Proceedings/files/RAN24_Proceedings.pdf

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos